phosphatidylcholines has been researched along with Sarcoma, Kaposi in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Azarnia, N; Barrueco, JR; Cheung, TW; Dezube, BJ; Proper, JA; Remick, SC | 1 |
1 trial(s) available for phosphatidylcholines and Sarcoma, Kaposi
Article | Year |
---|---|
AIDS-related Kaposi's sarcoma: a phase II study of liposomal doxorubicin. The TLC D-99 Study Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Antineoplastic Agents; CD4 Lymphocyte Count; Cholesterol; Confidence Intervals; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Carriers; Humans; Liposomes; Male; Middle Aged; Phosphatidylcholines; Sarcoma, Kaposi; Skin Neoplasms; Time Factors | 1999 |